0001144204-18-059942.txt : 20181114
0001144204-18-059942.hdr.sgml : 20181114
20181114160719
ACCESSION NUMBER: 0001144204-18-059942
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180930
FILED AS OF DATE: 20181114
DATE AS OF CHANGE: 20181114
EFFECTIVENESS DATE: 20181114
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProQuest Associates IV LLC
CENTRAL INDEX KEY: 0001431819
IRS NUMBER: 205934968
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16604
FILM NUMBER: 181183694
BUSINESS ADDRESS:
STREET 1: 2430 VANDERBILT BEACH ROAD
STREET 2: #108 - 190
CITY: NAPLES
STATE: FL
ZIP: 34109
BUSINESS PHONE: 609-919-3567
MAIL ADDRESS:
STREET 1: 2430 VANDERBILT BEACH ROAD
STREET 2: #108 - 190
CITY: NAPLES
STATE: FL
ZIP: 34109
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001431819
XXXXXXXX
09-30-2018
09-30-2018
false
ProQuest Associates IV LLC
2430 Vanderbilt Beach Road
#108 - 190
Naples
FL
34109
13F HOLDINGS REPORT
028-16604
Y
ProQuest Associates IV LLC is the general partner of ProQuest Investments IV, L.P. ProQuest Associates III LLC is the general partner of ProQuest Investments III, L.P. ProQuest Financial, L.L.C. is engaged as manager for ProQuest Associates IV LLC and ProQuest Associates III LLC but does not maintain investment and voting power with respect to securities held or controlled by them. Jay Moorin and Alain Schreiber, individuals, control ProQuest Associates IV LLC, ProQuest Associates III LLC and ProQuest Financial, L.L.C. ProQuest Associates IV LLC, ProQuest Associates III LLC, Jay Moorin and Alain Schreiber do not own any securities reported herein directly.
Pasquale DeAngelis
Member
609-919-3567
/s/ Pasquale DeAngelis
Buckingham
PA
11-14-2018
1
5
52956
1
0001306134
028-16603
ProQuest Associates III LLC
INFORMATION TABLE
2
infotable.xml
AGILE THERAPEUTICS, INC.
Common Stock
00847L100
718
1958875
SH
SOLE
1958875
0
0
AGILE THERAPEUTICS, INC.
Common Stock
00847L100
1137
3103488
SH
DFND
1
3103488
0
0
IMMUNE DESIGN CORP.
Common Stock
45252L103
4266
1236394
SH
SOLE
1236394
0
0
MERSANA THERAPEUTICS, INC.
Common Stock
59045L106
9557
955709
SH
DFND
1
955709
0
0
UROGEN PHARMA LTD.
Common Stock
M96088105
37278
789297
SH
SOLE
789297
0
0